Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marija Grozdanić

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Proteomics. Clinical Applications|July 11, 2019
Degradomics in Biomarker DiscoveryMarija Grozdanić, Robert Vidmar, Matej Vizovišek, et al.
Oncology Research|October 6, 2025
Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug ResistanceSofija Jovanović Stojanov, Marija Grozdanić, Mila Ljujić, et al.
Future Medicinal Chemistry|December 13, 2025
Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with <i>P</i>-glycoproteinMirjana Mosić, Ljiljana Koračak, Marija Grozdanić, et al.
Life (Basel, Switzerland)|September 28, 2024
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision MedicineJelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Biological Chemistry|October 27, 2023
Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancerMarija Grozdanić, Barbara Sobotič, Monika Biasizzo, et al.
Pharmaceutics|February 26, 2025
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular ModelsAna Podolski-Renić, Margarita Chigriai, Sofija Jovanović Stojanov, et al.
Molecules (Basel, Switzerland)|December 31, 2025
Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma CellsEma Lupšić, Pavle Stojković, Marija Grozdanić, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Proteomics. Clinical Applications|July 11, 2019
Degradomics in Biomarker DiscoveryMarija Grozdanić, Robert Vidmar, Matej Vizovišek, et al.
Oncology Research|October 6, 2025
Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug ResistanceSofija Jovanović Stojanov, Marija Grozdanić, Mila Ljujić, et al.
Future Medicinal Chemistry|December 13, 2025
Integrative lipophilicity assessment and pharmacokinetic correlation of pyrimidine precursors and artesunate-pyrimidine hybrids: development of QSAR models for anticancer activity and interaction with <i>P</i>-glycoproteinMirjana Mosić, Ljiljana Koračak, Marija Grozdanić, et al.
Life (Basel, Switzerland)|September 28, 2024
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision MedicineJelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, et al.
Biological Chemistry|October 27, 2023
Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancerMarija Grozdanić, Barbara Sobotič, Monika Biasizzo, et al.
Pharmaceutics|February 26, 2025
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular ModelsAna Podolski-Renić, Margarita Chigriai, Sofija Jovanović Stojanov, et al.
Molecules (Basel, Switzerland)|December 31, 2025
Novel Adamantane-Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma CellsEma Lupšić, Pavle Stojković, Marija Grozdanić, et al.
Pageof 1